HEADER IMMUNE SYSTEM 09-SEP-19 6KX1 TITLE CRYSTAL STRUCTURE OF SN-101 MAB IN COMPLEX WITH MUC1 GLYCOPEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FAB FRAGMENT-SN-101-HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: FAB FRAGMENT-SN-101-LIGHT CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SYNTHETIC MUC1 GLYCOPEPIDE; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: MOUSE; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: MOUSE; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 13 EXPRESSION_SYSTEM_COMMON: MOUSE; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606 KEYWDS ANTIBODY, IGG1, MUC1, GLYCOPEPTIDE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR H.WAKUI,Y.TANAKA,K.KATO,T.OSE,I.MATSUMOTO,Y.MIN,T.TACHIBANA,S.- AUTHOR 2 I.NISHIMURA REVDAT 2 22-NOV-23 6KX1 1 HETSYN REVDAT 1 29-JUL-20 6KX1 0 JRNL AUTH H.WAKUI,Y.TANAKA,T.OSE,I.MATSUMOTO,K.KATO,Y.MIN,T.TACHIBANA, JRNL AUTH 2 M.SATO,K.NARUCHI,F.G.MARTIN,H.HINOU,S.-I.NISHIMURA JRNL TITL A STRAIGHTFORWARD APPROACH TO ANTIBODIES RECOGNISING CANCER JRNL TITL 2 SPECIFIC GLYCOPEPTIDIC NEOEPITOPES JRNL REF CHEM SCI V. 11 4999 2020 JRNL REFN ESSN 2041-6539 JRNL DOI 10.1039/D0SC00317D REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 38800 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1939 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 3466 REMARK 3 ANGLE : 1.118 4721 REMARK 3 CHIRALITY : 0.062 531 REMARK 3 PLANARITY : 0.007 601 REMARK 3 DIHEDRAL : 12.458 2054 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6KX1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-SEP-19. REMARK 100 THE DEPOSITION ID IS D_1300013757. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38810 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.980 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.970 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1PZ5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 300-350 MM NASCN 20-30% PEG3350, PH REMARK 280 8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 79.96000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.99000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 79.96000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.99000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 ASP A -18 REMARK 465 LEU A -17 REMARK 465 ARG A -16 REMARK 465 LEU A -15 REMARK 465 SER A -14 REMARK 465 CYS A -13 REMARK 465 ALA A -12 REMARK 465 PHE A -11 REMARK 465 ILE A -10 REMARK 465 ILE A -9 REMARK 465 VAL A -8 REMARK 465 LEU A -7 REMARK 465 LEU A -6 REMARK 465 LYS A -5 REMARK 465 GLY A -4 REMARK 465 VAL A -3 REMARK 465 GLN A -2 REMARK 465 SER A -1 REMARK 465 GLU A 0 REMARK 465 SER A 130 REMARK 465 ALA A 131 REMARK 465 ALA A 132 REMARK 465 GLN A 133 REMARK 465 THR A 134 REMARK 465 ASP A 216 REMARK 465 MET B -18 REMARK 465 LYS B -17 REMARK 465 LEU B -16 REMARK 465 PRO B -15 REMARK 465 VAL B -14 REMARK 465 ARG B -13 REMARK 465 LEU B -12 REMARK 465 LEU B -11 REMARK 465 VAL B -10 REMARK 465 LEU B -9 REMARK 465 MET B -8 REMARK 465 PHE B -7 REMARK 465 TRP B -6 REMARK 465 ILE B -5 REMARK 465 PRO B -4 REMARK 465 ALA B -3 REMARK 465 SER B -2 REMARK 465 SER B -1 REMARK 465 SER B 0 REMARK 465 CYS B 220 REMARK 465 PRO C 11 REMARK 465 GLY C 12 REMARK 465 SER C 13 REMARK 465 THR C 14 REMARK 465 ALA C 15 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 135 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH22 ARG A 68 OD2 ASP A 91 1.50 REMARK 500 O HOH A 414 O HOH A 419 1.93 REMARK 500 O HOH B 308 O HOH B 311 2.01 REMARK 500 OG SER A 205 O HOH A 301 2.05 REMARK 500 OD1 ASP B 17 O HOH B 301 2.09 REMARK 500 NZ LYS B 205 O HOH B 302 2.11 REMARK 500 O HOH A 305 O HOH A 392 2.14 REMARK 500 OG SER A 54 O HOH A 302 2.17 REMARK 500 OH TYR A 57 O HOH A 303 2.17 REMARK 500 NH1 ARG C 8 O HOH C 201 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 411 O HOH B 399 1545 2.00 REMARK 500 O HOH A 309 O HOH A 346 2656 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 68 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 68 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 51 -158.37 -103.02 REMARK 500 SER A 162 -29.83 -146.80 REMARK 500 VAL B 56 -44.23 72.64 REMARK 500 SER B 57 -2.83 -141.38 REMARK 500 ASN B 218 75.46 -67.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 ACE IN CHAIN C IS ACETYLATION. DBREF 6KX1 A -19 216 PDB 6KX1 6KX1 -19 216 DBREF 6KX1 B -18 220 PDB 6KX1 6KX1 -18 220 DBREF 6KX1 C 0 15 PDB 6KX1 6KX1 0 15 SEQRES 1 A 236 MET ASP LEU ARG LEU SER CYS ALA PHE ILE ILE VAL LEU SEQRES 2 A 236 LEU LYS GLY VAL GLN SER GLU VAL ASN LEU GLU GLU SER SEQRES 3 A 236 GLY GLY GLY LEU VAL GLN PRO GLY GLY SER MET LYS LEU SEQRES 4 A 236 SER CYS VAL ALA SER GLY PHE THR PHE SER ASN TYR TRP SEQRES 5 A 236 MET ASN TRP VAL ARG GLN SER PRO GLU LYS GLY LEU GLU SEQRES 6 A 236 TRP VAL ALA GLN ILE ARG LEU LYS SER ASP ASN TYR ALA SEQRES 7 A 236 THR HIS TYR ALA GLU SER VAL LYS GLY ARG PHE THR ILE SEQRES 8 A 236 SER ARG ASP ASP SER LYS SER SER VAL TYR LEU GLN MET SEQRES 9 A 236 ASN ASN LEU ARG ALA GLU ASP THR GLY ILE TYR TYR CYS SEQRES 10 A 236 THR GLY GLY VAL PHE ASP TYR TRP GLY GLN GLY THR THR SEQRES 11 A 236 LEU THR VAL SER SER SER LYS THR THR PRO PRO SER VAL SEQRES 12 A 236 TYR PRO LEU ALA PRO GLY SER ALA ALA GLN THR ASN SER SEQRES 13 A 236 MET VAL THR LEU GLY CYS LEU VAL LYS GLY TYR PHE PRO SEQRES 14 A 236 GLU PRO VAL THR VAL THR TRP ASN SER GLY ALA LEU SER SEQRES 15 A 236 SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER ASP SEQRES 16 A 236 LEU TYR THR LEU SER SER SER VAL THR VAL PRO SER SER SEQRES 17 A 236 THR TRP PRO SER GLN THR VAL THR CYS ASN VAL ALA HIS SEQRES 18 A 236 PRO ALA SER SER THR LYS VAL ASP LYS LYS ILE VAL PRO SEQRES 19 A 236 ARG ASP SEQRES 1 B 239 MET LYS LEU PRO VAL ARG LEU LEU VAL LEU MET PHE TRP SEQRES 2 B 239 ILE PRO ALA SER SER SER ASP VAL VAL MET THR GLN THR SEQRES 3 B 239 PRO LEU SER LEU PRO VAL SER LEU GLY ASP GLN ALA SER SEQRES 4 B 239 ILE SER CYS ARG SER SER GLN SER LEU VAL HIS SER ASN SEQRES 5 B 239 GLY ASN THR TYR LEU HIS TRP TYR LEU GLN LYS PRO GLY SEQRES 6 B 239 GLN SER PRO LYS LEU LEU ILE TYR LYS VAL SER ASN ARG SEQRES 7 B 239 PHE SER GLY VAL PRO ASP ARG PHE SER GLY SER GLY SER SEQRES 8 B 239 GLY THR ASP PHE THR LEU LYS ILE SER ARG VAL GLU ALA SEQRES 9 B 239 GLU ASP LEU GLY VAL TYR PHE CYS SER GLN SER THR HIS SEQRES 10 B 239 VAL PRO PRO TRP THR PHE GLY GLY GLY THR LYS LEU GLU SEQRES 11 B 239 ILE LYS ARG ALA ASP ALA ALA PRO THR VAL SER ILE PHE SEQRES 12 B 239 PRO PRO SER SER GLU GLN LEU THR SER GLY GLY ALA SER SEQRES 13 B 239 VAL VAL CYS PHE LEU ASN ASN PHE TYR PRO LYS ASP ILE SEQRES 14 B 239 ASN VAL LYS TRP LYS ILE ASP GLY SER GLU ARG GLN ASN SEQRES 15 B 239 GLY VAL LEU ASN SER TRP THR ASP GLN ASP SER LYS ASP SEQRES 16 B 239 SER THR TYR SER MET SER SER THR LEU THR LEU THR LYS SEQRES 17 B 239 ASP GLU TYR GLU ARG HIS ASN SER TYR THR CYS GLU ALA SEQRES 18 B 239 THR HIS LYS THR SER THR SER PRO ILE VAL LYS SER PHE SEQRES 19 B 239 ASN ARG ASN GLU CYS SEQRES 1 C 16 ACE VAL THR SER ALA PRO ASP THR ARG PRO ALA PRO GLY SEQRES 2 C 16 SER THR ALA HET ACE C 0 6 HET A2G C 101 28 HETNAM ACE ACETYL GROUP HETNAM A2G 2-ACETAMIDO-2-DEOXY-ALPHA-D-GALACTOPYRANOSE HETSYN A2G N-ACETYL-ALPHA-D-GALACTOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 A2G ALPHA-D-GALACTOSE; 2-ACETAMIDO-2-DEOXY-D-GALACTOSE; 2- HETSYN 3 A2G ACETAMIDO-2-DEOXY-GALACTOSE; N-ACETYL-2-DEOXY-2-AMINO- HETSYN 4 A2G GALACTOSE FORMUL 3 ACE C2 H4 O FORMUL 4 A2G C8 H15 N O6 FORMUL 5 HOH *237(H2 O) HELIX 1 AA1 THR A 27 TYR A 31 5 5 HELIX 2 AA2 LEU A 52 ASN A 56 5 5 HELIX 3 AA3 GLU A 63 LYS A 66 5 4 HELIX 4 AA4 ARG A 88 THR A 92 5 5 HELIX 5 AA5 SER A 158 ALA A 160 5 3 HELIX 6 AA6 SER A 188 TRP A 190 5 3 HELIX 7 AA7 PRO A 202 SER A 205 5 4 HELIX 8 AA8 GLU B 84 LEU B 88 5 5 HELIX 9 AA9 SER B 127 SER B 133 1 7 HELIX 10 AB1 LYS B 189 GLU B 193 1 5 SHEET 1 AA1 4 ASN A 2 SER A 6 0 SHEET 2 AA1 4 MET A 17 SER A 24 -1 O VAL A 22 N GLU A 4 SHEET 3 AA1 4 SER A 79 MET A 84 -1 O MET A 84 N MET A 17 SHEET 4 AA1 4 PHE A 69 ASP A 74 -1 N THR A 70 O GLN A 83 SHEET 1 AA2 6 GLY A 9 VAL A 11 0 SHEET 2 AA2 6 THR A 109 VAL A 113 1 O THR A 110 N GLY A 9 SHEET 3 AA2 6 GLY A 93 GLY A 99 -1 N TYR A 95 O THR A 109 SHEET 4 AA2 6 MET A 33 SER A 39 -1 N VAL A 36 O TYR A 96 SHEET 5 AA2 6 GLY A 43 ILE A 50 -1 O GLU A 45 N ARG A 37 SHEET 6 AA2 6 THR A 59 TYR A 61 -1 O HIS A 60 N GLN A 49 SHEET 1 AA3 4 GLY A 9 VAL A 11 0 SHEET 2 AA3 4 THR A 109 VAL A 113 1 O THR A 110 N GLY A 9 SHEET 3 AA3 4 GLY A 93 GLY A 99 -1 N TYR A 95 O THR A 109 SHEET 4 AA3 4 TYR A 104 TRP A 105 -1 O TYR A 104 N GLY A 99 SHEET 1 AA4 4 SER A 122 LEU A 126 0 SHEET 2 AA4 4 MET A 137 TYR A 147 -1 O LEU A 143 N TYR A 124 SHEET 3 AA4 4 LEU A 176 PRO A 186 -1 O LEU A 179 N VAL A 144 SHEET 4 AA4 4 VAL A 165 THR A 167 -1 N HIS A 166 O SER A 182 SHEET 1 AA5 4 SER A 122 LEU A 126 0 SHEET 2 AA5 4 MET A 137 TYR A 147 -1 O LEU A 143 N TYR A 124 SHEET 3 AA5 4 LEU A 176 PRO A 186 -1 O LEU A 179 N VAL A 144 SHEET 4 AA5 4 VAL A 171 GLN A 173 -1 N GLN A 173 O LEU A 176 SHEET 1 AA6 3 THR A 153 TRP A 156 0 SHEET 2 AA6 3 THR A 196 HIS A 201 -1 O ASN A 198 N THR A 155 SHEET 3 AA6 3 THR A 206 LYS A 211 -1 O THR A 206 N HIS A 201 SHEET 1 AA7 4 MET B 4 THR B 7 0 SHEET 2 AA7 4 ALA B 19 SER B 25 -1 O ARG B 24 N THR B 5 SHEET 3 AA7 4 ASP B 75 ILE B 80 -1 O ILE B 80 N ALA B 19 SHEET 4 AA7 4 PHE B 67 SER B 72 -1 N SER B 68 O LYS B 79 SHEET 1 AA8 6 SER B 10 SER B 14 0 SHEET 2 AA8 6 THR B 108 LYS B 113 1 O GLU B 111 N LEU B 11 SHEET 3 AA8 6 GLY B 89 GLN B 95 -1 N TYR B 91 O THR B 108 SHEET 4 AA8 6 LEU B 38 GLN B 43 -1 N GLN B 43 O VAL B 90 SHEET 5 AA8 6 PRO B 49 TYR B 54 -1 O LEU B 52 N TRP B 40 SHEET 6 AA8 6 ASN B 58 ARG B 59 -1 O ASN B 58 N TYR B 54 SHEET 1 AA9 4 SER B 10 SER B 14 0 SHEET 2 AA9 4 THR B 108 LYS B 113 1 O GLU B 111 N LEU B 11 SHEET 3 AA9 4 GLY B 89 GLN B 95 -1 N TYR B 91 O THR B 108 SHEET 4 AA9 4 THR B 103 PHE B 104 -1 O THR B 103 N GLN B 95 SHEET 1 AB1 4 THR B 120 PHE B 124 0 SHEET 2 AB1 4 GLY B 135 PHE B 145 -1 O PHE B 141 N SER B 122 SHEET 3 AB1 4 TYR B 179 THR B 188 -1 O LEU B 187 N ALA B 136 SHEET 4 AB1 4 VAL B 165 TRP B 169 -1 N SER B 168 O SER B 182 SHEET 1 AB2 4 SER B 159 ARG B 161 0 SHEET 2 AB2 4 ASN B 151 ILE B 156 -1 N ILE B 156 O SER B 159 SHEET 3 AB2 4 SER B 197 THR B 203 -1 O THR B 203 N ASN B 151 SHEET 4 AB2 4 ILE B 211 ASN B 216 -1 O ILE B 211 N ALA B 202 SSBOND 1 CYS A 21 CYS A 97 1555 1555 2.06 SSBOND 2 CYS A 142 CYS A 197 1555 1555 2.00 SSBOND 3 CYS B 23 CYS B 93 1555 1555 2.09 SSBOND 4 CYS B 140 CYS B 200 1555 1555 2.13 LINK C ACE C 0 N VAL C 1 1555 1555 1.46 LINK OG1 THR C 7 C1 A2G C 101 1555 1555 1.40 CISPEP 1 VAL A 101 PHE A 102 0 9.95 CISPEP 2 PHE A 148 PRO A 149 0 -5.43 CISPEP 3 GLU A 150 PRO A 151 0 -4.09 CISPEP 4 TRP A 190 PRO A 191 0 11.29 CISPEP 5 THR B 7 PRO B 8 0 -5.73 CISPEP 6 VAL B 99 PRO B 100 0 -10.57 CISPEP 7 PRO B 100 PRO B 101 0 -2.99 CISPEP 8 TYR B 146 PRO B 147 0 1.87 CRYST1 159.920 39.980 63.870 90.00 100.56 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006253 0.000000 0.001166 0.00000 SCALE2 0.000000 0.025013 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015927 0.00000